Samuel R. Heaps

Samuel R. Heaps

Auto-generated profile, based on publicly available information

Samuel R. Heaps

Department of Intelligent Systems Engineering, Indiana University, Bloomington, IN, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2020 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
TST. J. Sego
T. J. Sego
JAJosua O. Aponte-Serrano
Josua O. Aponte-Serrano
JGJuliano Ferrari Gianlupi
Juliano Ferrari Gianlupi
SHSamuel R. Heaps
Samuel R. Heaps
KBKira Breithaupt
Kira Breithaupt
JGJames A. Glazier
James A. Glazier
Simulations of tissue-specific effects of primary acute viral infections like COVID-19 are essential for understanding disease outcomes and optimizing therapies. Such simulations need to support continuous updating in response to rapid advances in understanding of infection mechanisms, and parallel development of components by multiple groups. We present an open-source platform for multiscale spatiotemporal simulation of an epithelial tissue, viral infection, cellular immune response and tissue damage, specifically designed to be modular and extensible to support continuous updating and parallel development. The base simulation of a simplified patch of epithelial tissue and immune response exhibits distinct patterns of infection dynamics from widespread infection, to recurrence, to clearance. Slower viral internalization and faster immune-cell recruitment slow infection and promote containment. Because antiviral drugs can have side effects and show reduced clinical effectiveness when given later during infection, we studied the effects on progression of treatment potency and time-of-first treatment after infection. In simulations, even a low potency therapy with a drug which reduces the replication rate of viral RNA greatly decreases the total tissue damage and virus burden when given near the beginning of infection. Many combinations of dosage and treatment time lead to stochastic outcomes, with some simulation replicas showing clearance or control (treatment success), while others show rapid infection of all epithelial cells (treatment failure). Thus, while a high potency therapy usually is less effective when given later, treatments at late times are occasionally effective. We illustrate how to extend the platform to model specific virus types (e.g., hepatitis C) and add additional cellular mechanisms (tissue recovery and variable cell susceptibility to infection), using our software modules and publicly-available software repository.

1 October 2021 in Environmental Pollution
Verified
Journal Article
Closed access
JCJason A. Coral
Jason A. Coral
SHSamuel Heaps
Samuel Heaps
SGStephen P. Glaholt
Stephen P. Glaholt
JKJonathan A. Karty
Jonathan A. Karty
SJStephen C. Jacobson
Stephen C. Jacobson
MBMaria Bondesson
Maria Bondesson